Molecular Markers Associated With the Response to Therapy With Everolimus in Patients With Renal Cell Carcinoma

Siberian Journal of Oncology- Russian Federation

doi 10.21294/1814-4861-2016-15-2-42-47

Full Text

Abstract

Available in

Date

Authors

Publisher

Tomsk Cancer Research Institute

Related search

Pcn92 - The Evaluation of the Economic Efficiency of Lenvatinib in Combination With Everolimus in Russian Patients With Disseminated Renal Cell Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Clinical Genitourinary Cancer
OncologyUrology
2017English

Salvage Ipilimumab Associated With a Significant Response in Sarcomatoid Renal Cell Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2018English

Decreased TCL6 Expression Is Associated With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2016English

Metastatic Renal Cell Carcinoma With Level IV Thrombus: Contemporary Management With Complete Response to Neoadjuvant Targeted Therapy

Case Reports in Urology
2019English

Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Acanthosis Nigricans Associated With Clear-Cell Renal Cell Carcinoma

Autopsy and Case Reports
2016English

Prognostic Factors in Patients With Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy